P

AIM-IHC Breast Panel

Application

by PathAI

AIM-IHC Breast Panel provides AI-generated scoring of breast cancer biomarkers HER2, ER, PR, and Ki-67.

Find alternatives to AIM-IHC Breast Panel

What it does

• Medical imaging analysis

Features 4

• AIM-HER2 BreastAI scoring of HER2 (0, 1+, 2+, 3+) with invasive carcinoma area and heatmap, compatible with multiple clones and scanners.
• AIM-Ki-67 BreastAI quantification of Ki-67 in breast cancer, compatible with multiple clones and scanners.
• AIM-ER BreastAI quantification of estrogen receptor in breast cancer, compatible with multiple clones and scanners.
• AIM-PR BreastAI quantification of progesterone receptor in breast cancer, compatible with multiple clones and scanners.

Sources

Pricing

Official documentation · 14 Oct 2026

"our business development team"

Description

Official documentation · 14 Oct 2026

"HER2, ER, PR, and Ki-67"

What it does

Official documentation · 14 Oct 2026

"AI-generated scoring of Breast Cancer IHC"

Sold within

Official documentation · 14 Oct 2026

"Available now on the AISight®"

Name

Official documentation · 14 Oct 2026

"Introducing AIM-IHC Breast Panel"

URL

Official documentation · 14 Oct 2026

"Introducing AIM-IHC Breast Panel"

Deployment

Official documentation · 14 Oct 2026

"within a unified, cloud-native platform"

Also from PathAI

• AISight Platform

  Digital pathology platform with an image management system (research use), AISight Dx (FDA 510(k) cleared, and CE-IVDR marked) and AI algorithm products for biopharma translational research and clinical development.

• ArtifactDetect Application

  ArtifactDetect automatically detects and highlights artifacts that may affect slide evaluations.

• TumorDetect Application

  TumorDetect analyzes whole-slide images to identify cases with likely tumors for prioritization.

• AIM-TumorCellularity Application

  AIM-TumorCellularity quantifies tumor and tissue areas to support tumor cellularity assessment.

• AIM-PD-L1 Application

  AIM-PD-L1 detects and quantifies PD-L1-positive tumor and immune cells in pathology images.

• AIM-HI Ulcerative Colitis Application

  AIM-HI Ulcerative Colitis provides AI-assisted histologic scoring for ulcerative colitis clinical trial assessment and research.

Open PathAI in the directory

Something wrong here? Send a correction — quote this product id: pathai-aim-ihc-breast-panel.